Gastrointestinal transit measurements in mice with 99mTc-DTPA-labeled activated charcoal using NanoSPECT-CT

Springer Science and Business Media LLC - Tập 3 - Trang 1-8 - 2013
Parasuraman Padmanabhan1,2, Johannes Grosse3, Abu Bakar Md Ali Asad1, George K Radda1, Xavier Golay1,4
1Laboratory of Molecular Imaging, Singapore Bioimaging Consortium (SBIC), Singapore, Singapore
2The Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore
3Takeda Cambridge Ltd., Cambridge, UK
4UCL Institute of Neurology, London, UK

Tóm tắt

Gastrointestinal (GI) disorders are commonly associated with chronic conditions such as diabetes, obesity, and hypertension. Direct consequences are obstipation or diarrhea as opposite aspects of the irritable bowel syndrome, and more indirectly, alteration of appetite, feeling of fullness, flatulence, bloatedness, and eventually leading to altered absorption of nutrients. Moreover, GI retention and passage times have been recognized as important factors in determining the release site and hence the bioavailability of orally administered drugs. To facilitate the understanding of physiological and pathological processes involved, it is necessary to monitor the gut motility in animal models. Here, we describe a method for studying the GI transit time using technetium-labeled activated charcoal diethylenetriaminepentaacetic acid (99mTc-Ch-DTPA) detected by single-photon emission computed tomography (SPECT). Tc-DTPA was adsorbed onto activated charcoal and administered orally to trypan blue-tainted (n = 4) 129SvEv mice (50 to 80 MBq/animal, n = 11). The exact distribution and movement of radioactivity in the gastrointestinal tract was measured at intervals of 1, 3, 6, 12, and 22 h by SPECT-CT. In addition, in order to validate the imaging of GI transient time, loperamide (0.25 mg/animal, n = 3) was used to delay the GI transit. The transit time measured as the peak radioactivity occurring in the rectum was 6 to 7 h after gavaging of 99mTc-Ch-DTPA. After 1 h, the bolus had passed into the small intestine and entered the cecum and the colon. At 6 and 8 h, the cecum, the ascending, transverse, and descending colon, and the rectum showed significant labeling. Several pellets were stored in the rectum for defecation. After 22 h, little activity remained in the stomach and none was detected in the transverse colon or other GI locations. In contrast, 6 h after administration of loperamide, only the cecum and part of the transverse colon were labeled. After 22 h, both structures retained significant amount of label. This delay has been verified by non-radiolabeled dye trypan blue GI measurements (n = 4). Here, we present the first non-invasive study of mouse GI transit time, allowing clear differentiation between vehicle- and loperamide-treated animals. This technique is useful for the investigation of GI motility in mice.

Tài liệu tham khảo

Lin H, Prather C, Fisher R, Meyer J, Summers R, Pimentel M, McCallum R, Akkermans L, Loening-Baucke V: Measurement of gastrointestinal transit. Dig Dis Sci 2005, 50: 989–1004. Abrahamsson H, Antov S, Bosaeus I: Gastrointestinal and colonic segmental transit time evaluated by a single abdominal X-ray in healthy subjects and constipated patients. Scand J Gastroenterol 1988, 23: 72–80. Camilleri M, Colemont LJ, Phillips SF, Brown ML, Thomforde GM, Chapman N, Zinsmeister AR: Human gastric emptying and colonic filling of solids characterized by a new method. Am J Physiol Gastrointest Liver Physiol 1989, 257: G284–290. Amend M, Greiner L: The ultrasound capsule: a new method for measurement of gastrointestinal motility. Ultraschall Med 1996, 17: 274–276. 10.1055/s-2007-1003197 Ewe K, Press AG, Dederer W: Gastrointestinal transit of undigestible solids measured by metal detector EAS II. Eur J Clin Invest 1989, 19: 291–297. 10.1111/j.1365-2362.1989.tb00232.x Weitschies W, Wedemeyer J, Stehr R, Trahms L: Magnetic markers as a noninvasive tool to monitor gastrointestinal transit. IEEE Trans Biomed Eng 1994, 41: 192–195. 10.1109/10.284931 Leng-Peschlow E: Effect of sennosides and related compounds on intestinal transit in the rat. Pharmacology 1988,36(Suppl 1):40–48. Mayer EA, Bradesi S, Chang L, Spiegel BM, Bueller JA, Naliboff BD: Functional GI disorders: from animal models to drug development. Gut 2008, 57: 384–404. 10.1136/gut.2006.101675 Theodorakis MC: External scintigraphy in measuring rate of gastric emptying in beagles. Am J Physiol 1980, 239: G39–43. Tan-No K, Niijima F, Nakagawasai O, Sato T, Satoh S, Tadano T: Development of tolerance to the inhibitory effect of loperamide on gastrointestinal transit in mice. Eur J Pharm Sci 2003, 20: 357–363. 10.1016/j.ejps.2003.08.004 Iwanaga Y, Wen J, Thollander MS, Kost LJ, Thomforde GM, Allen RG, Phillips SF: Scintigraphic measurement of regional gastrointestinal transit in the dog. Am J Physiol 1998, 275: G904–910. McDowell A, Nicoll JJ, McLeod BJ, Tucker IG, Davies NM: Gastrointestinal transit in the common brushtail possum measured by gamma scintigraphy. Int J Pharm 2005, 302: 125–132. 10.1016/j.ijpharm.2005.06.026 Burton DD, Camilleri M, Mullan BP, Forstrom LA, Hung JC: Colonic transit scintigraphy labeled activated charcoal compared with ion exchange pellets. J Nucl Med 1997, 38: 1807–1810. McDowell A, McLeod B, Thompson E, Tucker I: A morphometric study of the gastrointestinal tract of the common brushtail possum in southern New Zealand. Aust Mamm 2005, 27: 61–67. Vera DR, Stadalnik RC, Krohn KA: Technetium-99m galactosyl-neoglycoalbumin: preparation and preclinical studies. J Nucl Med 1985, 26: 1157–1167. Dublineau I, Grison S, Baudelin C, Dudoignon N, Souidi M, Marquette C, Paquet F, Aigueperse J, Gourmelon P: Absorption of uranium through the entire gastrointestinal tract of the rat. Int J Radiat Biol 2005, 81: 473–482. 10.1080/09553000500196029